Related references
Note: Only part of the references are listed.Biomarker LEPRE1 induces pelitinib-specific drug responsiveness by regulating ABCG2 expression and tumor transition states in human leukemia and lung cancer
A-Ram Lee et al.
SCIENTIFIC REPORTS (2022)
Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
Xuechun Wang et al.
CELLS (2022)
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
Leah Davis et al.
CANCERS (2022)
CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma
Jing Wang et al.
EMBO JOURNAL (2022)
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma
Jin Zhou et al.
MOLECULAR CELL (2022)
Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment
Peipei Yang et al.
MEDICAL ONCOLOGY (2022)
Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment
Anup S. Pathania et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Immunometabolism in the Tumor Microenvironment
Dominic G. Roy et al.
ANNUAL REVIEW OF CANCER BIOLOGY, VOL 5, 2021 (2021)
The potential of long noncoding RNAs for precision medicine in human cancer
Mingming Wu et al.
CANCER LETTERS (2021)
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer
Michael Skwarski et al.
CLINICAL CANCER RESEARCH (2021)
Hypoxia-Induced Non-Coding RNAs Controlling Cell Viability in Cancer
Maria Magdalena Barreca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease
Eric Jonasch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The emerging role of KDM5A in human cancer
Guan-Jun Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors
Jang Hyun Park et al.
NATURE IMMUNOLOGY (2021)
ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
Wentong Fang et al.
ELIFE (2021)
Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase
Megan H. Trager et al.
ENDOCRINOLOGY (2021)
Lactate in the tumour microenvironment: From immune modulation to therapy
Zi-Hao Wang et al.
EBIOMEDICINE (2021)
Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma
Rouven Hoefflin et al.
CANCERS (2021)
Cell-programmed nutrient partitioning in the tumour microenvironment
Bradley Reinfeld et al.
NATURE (2021)
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K. Choueiri et al.
NATURE MEDICINE (2021)
The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis
Pei-Hua Peng et al.
BIOMEDICAL JOURNAL (2021)
The HIF complex recruits the histone methyltransferase SET1B to activate specific hypoxia-inducible genes
Brian M. Ortmann et al.
NATURE GENETICS (2021)
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Hypoxia and the Tumor Microenvironment
Yue Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell
Marco De Martino et al.
TRANSLATIONAL CANCER RESEARCH (2021)
Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis
Qian Zheng et al.
THERANOSTICS (2021)
Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism
Ilaria Elia et al.
NATURE METABOLISM (2021)
Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis
Antonella Carella et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee et al.
FASEB JOURNAL (2020)
Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
Pearl Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss
Lianxin Hu et al.
CANCER DISCOVERY (2020)
Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
Ya Luo et al.
FRONTIERS IN ONCOLOGY (2020)
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C. McDonald et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
ASIP COTRAN EARLY CAREER INVESTIGATOR AWARD LECTURE Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases
Chengheng Liao et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Chao Shen et al.
CELL STEM CELL (2020)
Crosstalk Between Hypoxia and ER Stress Response: A Key Regulator of Macrophage Polarization
Paula Diaz-Bulnes et al.
FRONTIERS IN IMMUNOLOGY (2020)
USP37 promotes deubiquitination of HIF2 α in cancer
Kai Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss
Xijuan Liu et al.
MOLECULAR CELL (2020)
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer
Sophie J. Cowman et al.
CLINICAL CANCER RESEARCH (2020)
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Anmi Jose et al.
CANCERS (2020)
Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma
Zachary A. Bacigalupa et al.
CANCER LETTERS (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Chengheng Liao et al.
CANCER DISCOVERY (2020)
TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation
Sijia Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Aspartate β-hydroxylase as a target for cancer therapy
Madiha Kanwal et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
The roles of long noncoding RNAs in breast cancer metastasis
Lingxia Liu et al.
CELL DEATH & DISEASE (2020)
Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity
Charles W. Tran et al.
PLOS ONE (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
2-Oxoglutarate-dependent dioxygenases in cancer
Julie-Aurore Losman et al.
NATURE REVIEWS CANCER (2020)
Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Rongchen Shi et al.
MEDCOMM (2020)
The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer
Xijuan Liu et al.
CULLIN-RING LIGASES AND PROTEIN NEDDYLATION: BIOLOGY AND THERAPEUTICS (2020)
Signaling in and out: long-noncoding RNAs in tumor hypoxia
Tse-Chun Kuo et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC
Hung-Jung Wang et al.
ONCOGENE (2019)
Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer
Krishna M. Sinha et al.
ONCOGENE (2019)
Histone modifiers are oxygen sensors
Paolo Gallipoli et al.
SCIENCE (2019)
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
Abhishek A. Chakraborty et al.
SCIENCE (2019)
Hypoxia induces rapid changes to histone methylation and reprograms chromatin
Michael Batie et al.
SCIENCE (2019)
KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis
Meng-Chen Wu et al.
CELL DEATH & DISEASE (2019)
HIF Inhibitors: Status of Current Clinical Development
Jaleh Fallah et al.
CURRENT ONCOLOGY REPORTS (2019)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells
Sabrina Pengam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Matthew E. Cockmann et al.
ELIFE (2019)
Long Non-coding RNAs as Communicators and Mediators Between the Tumor Microenvironment and Cancer Cells
Di Chen et al.
FRONTIERS IN ONCOLOGY (2019)
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis
Matthew G. Oser et al.
GENES & DEVELOPMENT (2019)
Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels
Xiaopei Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Xiaohu Zheng et al.
NATURE IMMUNOLOGY (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Long non-coding RNAs involved in cancer metabolic reprogramming
Hui Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
Dongling Zou et al.
CANCER CELL INTERNATIONAL (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
Eleni-Kyriaki Vetsika et al.
CELLS (2019)
KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia
Xin Xu et al.
LEUKEMIA & LYMPHOMA (2018)
Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1
Bin Dai et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy
Dayana B. Rivadeneira et al.
CLINICAL CANCER RESEARCH (2018)
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D
Kazumasa Komura et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia
Di Zhan et al.
LEUKEMIA RESEARCH (2018)
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Jing Zhang et al.
SCIENCE (2018)
PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
Wuhua Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
Martin Benej et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells
Hamza Celik et al.
CANCER CELL (2018)
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara et al.
CANCER CELL (2018)
Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication
Yang-Hsiang Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response
Fan Xuan et al.
CELL DEATH & DISEASE (2018)
Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
Monica Parodi et al.
FRONTIERS IN IMMUNOLOGY (2018)
A history of exploring cancer in context
Shelly Maman et al.
NATURE REVIEWS CANCER (2018)
Long non-coding RNA DANCR stabilizes HIF-1 alpha and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma
Xin Wen et al.
THERANOSTICS (2018)
The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
C. Wilson et al.
ONCOGENE (2017)
TET2 binds the androgen receptor and loss is associated with prostate cancer
M. L. Nickerson et al.
ONCOGENE (2017)
Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
Ishna N. Mistry et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor
G. Xie et al.
ONCOGENE (2017)
Lactic Acid: No Longer an Inert and End-Product of Glycolysis
Shiren Sun et al.
PHYSIOLOGY (2017)
G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis
Francesco Casciello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Targeting pH regulating proteins for cancer therapy-Progress and limitations
Scott K. Parks et al.
SEMINARS IN CANCER BIOLOGY (2017)
Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure
Eunyoung Tak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression
Jing-Wen Shih et al.
NATURE COMMUNICATIONS (2017)
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism
Weinan Du et al.
NATURE COMMUNICATIONS (2017)
HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells
Xin-gang Cui et al.
ONCOTARGET (2017)
Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
Yael Gropper et al.
CELL REPORTS (2017)
TET2 in Normal and Malignant Hematopoiesis
Robert L. Bowman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment
Kathrin Renner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma The ARISER Randomized Clinical Trial
Karim Chamie et al.
JAMA ONCOLOGY (2017)
Targeting immunosuppressive adenosine in cancer (vol 17, pg 709, 2017)
Dipti Vijayan et al.
NATURE REVIEWS CANCER (2017)
Regulation of immunity and inflammation by hypoxia in immunological niches
Cormac T. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2017)
lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia
Lingjuan Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Asis Palazon et al.
CANCER CELL (2017)
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Chayanon Ngambenjawong et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters
Ibtissam Marchiq et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer
Hui Liu et al.
MOLECULAR CARCINOGENESIS (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
The impact of hypoxia on tumor-associated macrophages
Anne-Theres Henze et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Restricting Glutamine or Glutamine-Dependent Purine and Pyrimidine Syntheses Promotes Human T Cells with High FOXP3 Expression and Regulatory Properties
Barbara Metzler et al.
JOURNAL OF IMMUNOLOGY (2016)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
Edouard Mullarky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner
Jianping Guo et al.
SCIENCE (2016)
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
Thomas M. Ashton et al.
NATURE COMMUNICATIONS (2016)
Prognostic Significance of Carbonic Anhydrase IX expression in Cancer Patients: A Meta-Analysis
Simon J. A. van Kuijk et al.
FRONTIERS IN ONCOLOGY (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase
Qiong Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
The Contribution of Angiogenesis to the Process of Metastasis
Diane R. Bielenberg et al.
CANCER JOURNAL (2015)
PI3K-mTORC2 but not PI3K-mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma
Sofie Mohlin et al.
CANCER RESEARCH (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
A Lactate-Induced Response to Hypoxia
Dong Chul Lee et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Preethi Korangath et al.
CLINICAL CANCER RESEARCH (2015)
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
Gregg L. Semenza
CLINICAL SCIENCE (2015)
Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis
Wen-ming Chen et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions
Kathrin Renner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
TET1 is a tumor suppressor of hematopoietic malignancy
Luisa Cimmino et al.
NATURE IMMUNOLOGY (2015)
The emerging role of IncRNAs in cancer
Maite Huarte
NATURE MEDICINE (2015)
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
Huimin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
Dorota Klysz et al.
SCIENCE SIGNALING (2015)
PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy
S-C Wang et al.
CELL DEATH & DISEASE (2015)
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
Xiongjian Rao et al.
NATURE COMMUNICATIONS (2015)
OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer
Jae-Hwan Kim et al.
ONCOTARGET (2015)
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation
Dorota Klysz et al.
SCIENCE SIGNALING (2015)
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions
Khalid Saeed et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Long non-coding RNA-LET is a positive prognostic factor and exhibits tumor-suppressive activity in gallbladder cancer
Ming-zhe Ma et al.
MOLECULAR CARCINOGENESIS (2015)
PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer
K-H Lee et al.
ONCOGENE (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
Hypoxia-Sensitive Epigenetic Regulation of an Antisense-Oriented lncRNA Controls WT1 Expression in Myeloid Leukemia Cells
Gregory McCarty et al.
PLOS ONE (2015)
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
Joseph C. Walsh et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Hypoxic Regulation of Glutamine Metabolism through HIF1 and SIAH2 Supports Lipid Synthesis that Is Necessary for Tumor Growth
Ramon C. Sun et al.
CELL METABOLISM (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
CD47 Signaling Regulates the Immunosuppressive Activity of VEGF in T Cells
Sukhbir Kaur et al.
JOURNAL OF IMMUNOLOGY (2014)
Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport
Becky M. Bola et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze et al.
NATURE COMMUNICATIONS (2014)
HIF-1-Mediated Suppression of Acyl-CoA Dehydrogenases and Fatty Acid Oxidation Is Critical for Cancer Progression
De Huang et al.
CELL REPORTS (2014)
Suppression of TET1-Dependent DNA Demethylation Is Essential for KRAS-Mediated Transformation
Bo-Kuan Wu et al.
CELL REPORTS (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Julie-Aurore Losman et al.
GENES & DEVELOPMENT (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Klaus W. Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Antagonism between FOXO and MYC regulates cellular powerhouse
Barrie Peck et al.
FRONTIERS IN ONCOLOGY (2013)
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
Ernestina Marianna De Francesco et al.
BREAST CANCER RESEARCH (2013)
Disrupting proton dynamics and energy metabolism for cancer therapy
Scott K. Parks et al.
NATURE REVIEWS CANCER (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Oncogenic features of the JMJD2A histone demethylase in breast cancer
William L. Berry et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group
Verena I. Gaidzik et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
K. Hendricksen et al.
JOURNAL OF UROLOGY (2012)
Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A
Imari Mimura et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
Weibo Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Characterization of novel antisense HIF-1α transcripts in human cancers
Davide Bertozzi et al.
CELL CYCLE (2011)
Tyrosine Phosphorylation of Lactate Dehydrogenase A Is Important for NADH/NAD+ Redox Homeostasis in Cancer Cells
Jun Fan et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene
Chuan Shen et al.
CANCER DISCOVERY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
Max Yan et al.
BREAST CANCER RESEARCH (2011)
The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
Christopher P. Guise et al.
CANCER RESEARCH (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation
Datsun A. Hsia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Miao-Chih Tsai et al.
SCIENCE (2010)
Tumor Angiogenesis: Insights and Innovations
Fernando Nussenbaum et al.
JOURNAL OF ONCOLOGY (2010)
Control of Cyclin D1 and Breast Tumorigenesis by the EgIN2 Prolyl Hydroxylase
Qing Zhang et al.
CANCER CELL (2009)
Mitochondrial reactive oxygen species regulate hypoxic signaling
Robert B. Hamanaka et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
David R. Mole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PHD2Mutation and Congenital Erythrocytosis with Paraganglioma
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
G. Liu et al.
ONCOGENE (2009)
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
Xiaobo Xia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile
Angela Rita Elia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes
David Frescas et al.
NATURE (2007)
The N-terminal Transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1α and HIF-2α
Cheng-Jun Hu et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Hypoxia: A key regulator of angiogenesis in cancer
Debbie Liao et al.
CANCER AND METASTASIS REVIEWS (2007)
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
Huafeng Zhang et al.
CANCER CELL (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1
Nathan A. Baird et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effects of histone deacetylase inhibitors on HIF-1
Dongming Liang et al.
CELL CYCLE (2006)
HIF-dependent induction of adenosine A2B receptor in hypoxia
Tianqing Kong et al.
FASEB JOURNAL (2006)
Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition -: The role of HIF-1α, HIF-2α, and other pathways
Gareth P. Elvidge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
p53 stabilization and transactivation by a von Hippel-Lindau protein
Jae-Seok Roe et al.
MOLECULAR CELL (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells
D Yoshida et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells
Y Mizukami et al.
NATURE MEDICINE (2005)
Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system
H Okazawa et al.
JOURNAL OF IMMUNOLOGY (2005)
Hypoxia-responsive transcription factors
EP Cummins et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer
Y Mizukami et al.
CANCER RESEARCH (2004)
Hypoxia-inducible factor (HIF-1)α:: its protein stability and biological functions
JW Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2004)
Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: Mechanism and therapeutic implications
A Rapisarda et al.
CANCER RESEARCH (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response
P Vaupel et al.
ONCOLOGIST (2004)
Imaging of angiogenesis: from microscope to clinic
DM McDonald et al.
NATURE MEDICINE (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species
SM Bailey et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Share Paper
